X-Linked Agammaglobulinemia Fund

X-linked agammaglobulinemia (XLA) is a rare, inherited primary immune deficiency characterized by a near-complete absence of functional antibodies. This deficit results in significant vulnerability to infections. The condition is genetic and present from birth, overwhelmingly affecting males due to its X-linked inheritance pattern.

XLA is a lifelong condition requiring ongoing management. Individuals are prone to recurrent and severe bacterial infections, particularly affecting the respiratory tract, ears, sinuses, and gastrointestinal system. Without consistent immune-supportive treatment, infections can lead to permanent organ damage.

The condition has a substantial functional impact on daily life, often beginning in infancy. Individuals require regular medical monitoring, lifelong immune-supportive therapy, infection prevention strategies, and prompt treatment of infectious episodes. Frequent healthcare encounters, travel to specialty providers, and caregiver involvement are common and place ongoing strain on families.